However, the expression level of CXCR3 in clinical cancer samples is associated with metastatic potential and patients prognosis (Zhang Y. et al., 2018), and the affinity of CXCL11 for CXCR3 is the highest of the three selective ligands (Cole et al., 1998). Here, CXCL11 is linked to cancer.